Nutritional aspects of child and adolescent psychopharmacology

Pediatric Annals

Volumn 36, Issue 9, 2007, Pages 600-609

  Kaplan, Bonnie J ^a,c   Shannon, Scott ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b Northern Colorado Center for Holistic Medicine   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARNITINE; CHROMIUM; CYANOCOBALAMIN; DEXAMPHETAMINE; FLUOXETINE; FOLIC ACID; IMIPRAMINE; INOSITOL; IRON; LAMOTRIGINE; LITHIUM; MAGNESIUM; MAGNESIUM OXIDE; METHYLPHENIDATE; MULTIVITAMIN; PHENOBARBITAL; PHENYTOIN; RISPERIDONE; S ADENOSYLMETHIONINE; SELENIUM; SEROTONIN UPTAKE INHIBITOR; THIAMINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VERAPAMIL; ZINC; ZONISAMIDE;

ADOLESCENT HEALTH; ANEMIA; ATTENTION DEFICIT DISORDER; ATYPICAL DEPRESSION; BIPOLAR DISORDER; BRAIN FUNCTION; BULIMIA; CARDIOTOXICITY; CHILD HEALTH; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; COPPER DEFICIENCY; DEPRESSION; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENTIATION; DYSTHYMIA; FOOD DRUG INTERACTION; HAIR LOSS; HIGH RISK POPULATION; HUMAN; MANIA; MONOTHERAPY; MOOD DISORDER; NONHUMAN; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; OBSESSIVE COMPULSIVE DISORDER; PANIC; PATHOPHYSIOLOGY; PROFILE OF MOOD STATES; PSYCHOPHARMACOLOGY; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SCORING SYSTEM; SELENIUM DEFICIENCY; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; VITAMIN DEFICIENCY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; ZINC DEFICIENCY;

EID: 35948936810     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20070901-11     Document Type: Review

References (40)

1. Rock CL. Multivitamin-multimineral supplements: who uses them? Am J Clin Nutr. 2007;85(1):277S-279S.
2. Gibbard WB, Kaplan BJ, Clarke ME, Verhoef MJ. Dietary and nutritional interventions for children and adolescents with autistic spectrum disorders. Presented at: American Association of Child and Adolescent Psychiatry, 2007; San Diego, California.
3. Kaplan BJ, Crawford S, Field C, Simpson JS. Vitamins, minerals and mood: A scientific review. Psychol Bull. In press.
4. Ames B, Elson-Schwab I, Silver E. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): relevance to genetic disease and polymorphisms. Am J Clin Nutr. 2002;75(4):616-658.
5. Mischoulon D. Update and critique of natural remedies as antidepressant treatments. Psychiatr Clin North Am. 2007;30(1):51-68.
6. Scarna A, Gijsman HJ, McTavish SFB, Harmer CJ, Cowen PJ, Goodwin GM. Effects of a branched-chain amino acid drink in mania. Br J Psychiatry. 2003;182:210-213.
7. Settle JE. Nutritional supplements in psychiatry. In: Lake HH, Spiegel D, eds. Complementary and Alternative Treatments in Mental Health Care. Arlington: American Psychiatric Publishing; 2007:115-149.
8. Gaby A. A-Z Guide to Drug-Herb-Vitamin Interactions. New York: Three Rivers Press; 2006.
9. Moore C, Biederman J, Wozniak J, et al. Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study. Am J Psychiatry. 2006;163(2):316-318.
10. Nierenberg A, Ostacher M, Calabrese J, et al. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry. 2006;163(2):210-216.
11. Arnold LE, DiSilvestro RA. Zinc in attention-deficit hyperactivity disorder. J Child Adolesc Psychopharamacol. 2005;15(4):619-627.
12. Corwin EJ, Murray-Kolb LE, Beard JL. Low hemoglobin level is a risk factor for postpartum depression. J Nutr. 2003;133(12):4139-4142.
13. Beard JL, Hendricks MK, Perez EM, et al. Maternal iron deficiency anemia affects postpartum emotions and cognition. J Nutr. 2005;135(2):267-272.
14. Docherty JP, Sack DA, Roffman M, Finch M, Komorowski JR. A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving. J Psychiatr Pract. 2005;11(5):302-314.
15. Rayman M, Thompson A, Warren-Perry M, et al. Impact of selenium on mood and quality of life: a randomized, controlled trial. Biol Psychiatry. 2006;59(2):147-154.
16. Kaplan BJ, Crawford SG, Gardner B, Farrelly G. Treatment of mood lability and explosive rage with minerals and vitamins: Two case studies in children. J Child Adolesc Psychopharamacol. 2002;12(3):203-218.
17. Kaplan BJ, Fisher JE, Crawford SG, Field CJ, Kolb B. Improved mood and behavior during treatment with a mineral-vitamin supplement: An open-label case series. J Child Adolesc Psychopharamacol. 2004;14(1):115-122.
18. Kaplan BJ, Simpson JSA, Ferre RC, Gorman C, McMullen D, Crawford SG. Effective mood stabilization in bipolar disorder with a chelated mineral supplement. J Clin Psychiatry. 2001;62:936-944.
19. Popper CW. Do vitamins or minerals (apart from lithium) have mood-stabilizing effects? J Clin Psychiatry. 2001;62(12):933-935.
20. Simmons M. Nutritional approach to bipolar disorder. J Clin Psychiatry. 2002;64(3):338.
21. Hernandez R, Fernandez Mde L, Miranda G, Suastegui R. Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study. Rev invest Clin. 2005;57(4):522-531.
22. Zanardi R, Smeraldi E. A double-blind, randomised, controlled clinical trial of acetyl-L-carnitine vs. amisulpride in the treatment of dysthymia. Eur Neuropsychopharmacol. 2006;16(4):281-287.
23. Owen A, Batterham M, Probst Y, Grenier B, Tapsell L. Low plasma vitamin E levels in major depression: diet or disease? Eur J Clin Nutr. 2005;59(2):304-306.
24. Peng C, Glassman P, Trilli L, Hayes-Hunter J, Good C. Incidence and severity of potential drug-dietary supplement interactions in primary care patients: an exploratory study of 2 outpatient practices. Arch Intern Med. 2004;164(6):630-666.
25. Xu H, Rajesan R, Harper P, et al. Induction of cytochrome P450 1A by cow milk-based formula: a comparative study between human milk and formula. Br J Pharmacol. 2005;146(2):296-305.
26. Davidson JRT, Abraham K, Connor KM, McLeod MN. Effectiveness of chromium in atypical depression: A placebo-controlled trial. Biol Psychiatry. 2003;53(3):261-264.
27. Marchesini G, Bellini M, Natale S, et al. Psychiatric distress and health-related quality of life in obesity. Diabetes Nutr Metab. 2003;16(3):145-154.
28. Bell I, Edman J, Morrow F, et al. Vitamin B1, B2, and B6 augmentation of tricyclic anti-depressant treatment in geriatric depression with cognitive dysfunction. J Am Coll Nutr. 1992;11(2):159-163.
29. Heiden A, Frey R, Presslich O, Blasbichler T, Smetana R, Kasper S. Treatment of severe mania with intravenous magnesium sulphate as a supplementary therapy. Psychiatry Res. 1999;89(3):239-246.
30. Giannini AJ, Nakoneczie AM, Melemis SM, Venrresco J, Condon M. Magnesium oxide augmentation of verapamil maintenance therapy in mania. Psychiatry Res. 2000;93(1):83-87.
31. Ruetsch O, Viala A, Bardou H, Martin P, Vacheron M. Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management. Encephale. 2005;31(4 Pt 1):507-516.
32. Stang J, Story M, Harnack L, Neumark-Sztainer D. Relationships between vitamin and mineral supplement use, dietary intake, and dietary adequacy among adolescents. J Am Diet Assoc. 2000;100(8):905-910.
33. Rodin J, Mancuso J, Granger J, Nelbach E. Food cravings in relation to body mass index, restraint and estradiol levels: a repeated measures study in healthy women. Appetite. 1991;17(3):177-185.
34. Antalis C, Stevens L, Campbell M, Pazdro R, Ericson K, Burgess J. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids. 2006;75(4-5):299-308.
35. Brookes K, Chen W, Xu X, Taylor E, Asherson P Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006;60(10):1053-1061.
36. Hibbeln JR. Fish consumption and major depression. Lancet. 1998;351(9110):1213.
37. Johnson S. The multifaceted and widespread pathology of magnesium deficiency. Med Hypotheses. 2001;56(2):163-170.
38. Mayer AB. Historical changes in the mineral content of fruits and vegetables. British Food Journal. 1997;99(6):207-211.
39. Siwek M, Wrobel A, Dudek D, Nowak G, Zieba A. The role of copper and magnesium in the pathogenesis and treatment of affective disorders. Psychiatr Pol. 2005;39(5):911-920.
40. Fletcher RH, Fairfield KM. Vitamins for chronic disease prevention in adults: Clinical applications. JAMA. 2002;287(23):3127-2129.